Deep diversification of an AAV capsid protein by machine learning.

Journal: Nature biotechnology
PMID:

Abstract

Modern experimental technologies can assay large numbers of biological sequences, but engineered protein libraries rarely exceed the sequence diversity of natural protein families. Machine learning (ML) models trained directly on experimental data without biophysical modeling provide one route to accessing the full potential diversity of engineered proteins. Here we apply deep learning to design highly diverse adeno-associated virus 2 (AAV2) capsid protein variants that remain viable for packaging of a DNA payload. Focusing on a 28-amino acid segment, we generated 201,426 variants of the AAV2 wild-type (WT) sequence yielding 110,689 viable engineered capsids, 57,348 of which surpass the average diversity of natural AAV serotype sequences, with 12-29 mutations across this region. Even when trained on limited data, deep neural network models accurately predict capsid viability across diverse variants. This approach unlocks vast areas of functional but previously unreachable sequence space, with many potential applications for the generation of improved viral vectors and protein therapeutics.

Authors

  • Drew H Bryant
    Google Research, Mountain View, CA, USA.
  • Ali Bashir
    Google Research, Mountain View, CA, USA.
  • Sam Sinai
    Data Science, Dyno Therapeutics Inc, Cambridge, MA, United States.
  • Nina K Jain
    Wyss Institute for Biologically Inspired Engineering, Boston, MA, USA.
  • Pierce J Ogden
    Wyss Institute for Biologically Inspired Engineering, Boston, MA, USA.
  • Patrick F Riley
    Google Research, Mountain View, CA, USA.
  • George M Church
    Wyss Institute for Biologically Inspired Engineering , Boston, Massachusetts 02115, United States.
  • Lucy J Colwell
    Department of Chemistry, Cambridge University, Cambridge, UK. Electronic address: ljc37@cam.ac.uk.
  • Eric D Kelsic
    Applied Biology, Dyno Therapeutics Inc, Cambridge, MA, United States.